Home › Sakit sa Puso at Ugat ng Dugo › Utah › Salt Lake City
Pag-aaral pangklinika para sa Sakit sa Puso at Ugat ng Dugo sa Salt Lake City, UT
14 pag-aaral para sa Sakit sa Puso at Ugat ng Dugo ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Salt Lake City (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)
Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
- University of Utah Health Sciences Center, Salt Lake City
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Nagre-recruitPhase 3
- Olympus Family Medicine, Salt Lake City
Product Surveillance Registry
Nagre-recruitObservasyonal na pag-aaral
- Salt Lake City, Salt Lake City
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Nagre-recruitPhase 3
- Clinical Trial Site, Salt Lake City
- Clinical Trial Site, Bountiful · 9 mi ang layo
- Clinical Trial Site, Bountiful · 9 mi ang layo
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Nagre-recruit
- University of Utah, Salt Lake City
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Nagre-recruitPhase 3
- The University of Utah, Salt Lake City
- Progressive Clinical Research, Bountiful · 9 mi ang layo
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
Nagre-recruitPhase 4Malugod na tinatanggap ang malusog na boluntaryo
- VA Salt Lake City Healthcare System, Salt Lake City
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Nagre-recruitPhase 3
- Research Site, Bountiful · 9 mi ang layo
Global Paradise System US Post Approval Study
Nagre-recruitObservasyonal na pag-aaral
- St. Mark's Hospital, Salt Lake City
Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
Nagre-recruitPhase 3
- Primary Childrens Medical Center, Salt Lake City
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- University of Utah Hospital, Salt Lake City
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Nagre-recruit
- University of Utah Hospital, Salt Lake City
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
Nagre-recruitPhase 3
- Primary Childrens Medical Center, Salt Lake City
- Primary Childrens Medical Center, Salt Lake City
Randomized Trial of SGLT2i in Heart Transplant Recipients
Nagre-recruitPhase 4
- VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City
Pag-aaral para sa Sakit sa Puso at Ugat ng Dugo sa ibang lungsod
- Boston, MA37 pag-aaral
- New York City, NY33 pag-aaral
- Washington, DC28 pag-aaral
- Houston, TX24 pag-aaral
- Dallas, TX23 pag-aaral
- Cleveland, OH22 pag-aaral
- Atlanta, GA22 pag-aaral
- Chicago, IL21 pag-aaral
- Philadelphia, PA21 pag-aaral
- Pittsburgh, PA20 pag-aaral
- St. Louis, MO20 pag-aaral
- Nashville, TN18 pag-aaral
Iba pang pag-aaral sa Salt Lake City
- Non-Small Cell Lung Cancer31 pag-aaral
- Kanser (lahat ng uri)27 pag-aaral
- Kanser sa Suso27 pag-aaral
- Colorectal Cancer22 pag-aaral
- Kanser sa Baga21 pag-aaral
- Melanoma21 pag-aaral
- Multiple Myeloma21 pag-aaral
- Metastatic Cancer20 pag-aaral
- Kanser sa Ovary19 pag-aaral
- Obesity18 pag-aaral
- Acute Myeloid Leukemia17 pag-aaral
- Pagkabigo ng Puso17 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.